000 | 02794na a2200265 4500 | ||
---|---|---|---|
999 |
_c353 _d353 |
||
003 | PC353 | ||
005 | 20210625062753.0 | ||
008 | 130622s2013 xxx||||| |||| 00| 0 eng d | ||
040 | _cH12O | ||
041 | _aeng | ||
100 |
_aCaso, Javier Rubén _92439 _eInstituto de Investigación i+12 |
||
100 |
_aGarcía Bueno, Borja _91897 _eInstituto de Investigación i+12 |
||
100 |
_aHinojosa, Ara E _92627 _eInstituto de Investigación i+12 |
||
100 |
_aLeza, Juan Carlos _91995 _eInstituto de Investigación i+12 |
||
100 |
_aMadrigal, José LM _92628 _eInstituto de Investigación i+12 |
||
245 | 0 | 0 |
_aDual effects of noradrenaline on astroglial production of chemokines and pro-inflammatory mediators. _h[artículo] |
260 |
_bJournal of neuroinflammation, _c2013 |
||
300 | _a10:81. | ||
500 | _aFormato Vancouver: Hinojosa AE, Caso JR, García-Bueno B, Leza JC, Madrigal JL. Dual effects of noradrenaline on astroglial production of chemokines and pro-inflammatory mediators. J Neuroinflammation. 2013 Jul 9;10:81. | ||
501 | _aPMID: 23837880 | ||
504 | _aContiene 65 referencias | ||
520 | _aNoradrenaline (NA) is known to limit neuroinflammation. However, the previously described induction by NA of a chemokine involved in the progression of immune/inflammatory processes, such as chemokine (C-C motif) ligand 2 (CCL2)/monocyte chemotactic protein-1 (MCP-1), apparently contradicts NA anti-inflammatory actions. In the current study we analyzed NA regulation of astroglial chemokine (C-X3-C motif) ligand 1 (CX3CL1), also known as fractalkine, another chemokine to which both neuroprotective and neurodegenerative actions have been attributed. In addition, NA effects on other chemokines and pro-inflammatory mediators were also analyzed. | ||
710 |
_9625 _aInstituto de Investigación imas12 |
||
856 |
_uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3708781/ _yAcceso libre |
||
942 |
_n0 _2ddc _cART |